In the much-anticipated State of the Union, President Trump gave a few remarks on health care that signal his Administration’s agenda for 2019. This included lowering drug prices, boosting research on childhood cancer, ending the HIV/AIDS epidemic and banning late-term abortions. He also reiterated his commitment to price transparency, stating “We should also require drug companies, insurance companies and hospitals to disclose real prices to foster competition and bring costs down.” For further details on the President’s speech [included].

Also in Policy Brief:

  • U.S. Prescription Drug Pricing: What’s on the Horizon
  • New ACA-Related Proposal Raises Access Concerns
  • Price Transparency: The First Stepping Stone
  • Across the Nation: Stakeholders Address Social Determinants of Health
  • A Look at the Federal Register
View PDF